European Society for Medical Oncology (ESMO) position paper on supportive and palliative care

Por: Jordan K, Aapro M, Kaasa S, Ripamonti C, Scotte F, Strasser F, Young A, Bruera E, Herrstedt J, Keefe D, Laird B, Walsh D, Douillard J, Cervantes A

---

Publicada: 1 ene 2018

---

---

Filiaciones:
Jordan K:
 Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany

Aapro M:
 Cancer Center, Clinique de Genolier, Genolier, Switzerland

Kaasa S:
 Department of Oncology, Oslo University Hospital, Oslo, Norway

 University of Oslo, Oslo, Norway

 European Palliative Care Research Centre (PRC) NTNU, Oslo, Norway

Ripamonti C:
 Supportive Care in Cancer Unit, Department of Onco-Haematology Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy

Scotte F:
 Medical Oncology and Supportive Care Department, Foch Hospital, Suresnes, France

Strasser F:
 Oncological Palliative Medicine, Clinic for Medical Oncology and Hematology, Departement Internal Medicine, Cantonal Hospital St.Gallen, St. Gallen, Switzerland

Young A:
 Warwick Clinical Trials Unit, University of Warwick, Coventry, UK

Bruera E:
 Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas, MD Anderson Cancer Center, Houston, USA

Herrstedt J:
 Department of Oncology, Zealand University Hospital, Roskilde, Denmark

 Department of Oncology, University of Copenhagen, Copenhagen, Denmark

Keefe D:
 Department of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia

Laird B:
 Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK

 St Columba's Hospice, Edinburgh, UK

Walsh D:
 Academic Department of Palliative Medicine, Our Lady's Hospice and Care Services, Dublin, Ireland

Douillard J:
 ESMO, Lugano, Switzerland

Cervantes A:
 CIBERONC, Department of Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain